May, 31st 2019
Dr. Nina Bauer recently presented on the new ekko(TM) platform and several applications being developed with our customers
As cell and gene therapies approach commercialization, the industry is looking for scalable manufacturing solutions. Equipment providers need to design specifically for the good manufacturing practice (GMP) environment and the unique needs of cell and gene processing. On 3 April 2019, Kevin Lannon of FloDesign Sonics presented an “Ask the Expert” on one company’s solution.
FloDesign Sonics CEO Stanley Kowalski joined Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Massachusetts-based, privately-held company specializes in acoustophoresis, a process in which acoustic waves are used to process cells.
WILBRAHAM, Mass., Oct. 2, 2018 /PRNewswire/ -- FloDesign Sonics, a global leader in acoustic cell processing for cell and gene therapies, today announced their continued investment in attracting industry expertise and operational excellence with several key hires over the past few fiscal quarters.
Cell & Gene Therapy Insights: Critical Role of Automation in the Manufacture of Cell & Gene Therapies
Interview: Moving from Retrofitting to Made for Purpose Manufacturing Equipment. NINA BAUER, a key figure in the cell and gene therapy community joined FloDesign Sonics in September as VP of Business Development. RICHARD GRANT, Chief Product Officer of FloDesign Sonics, has 33 years of product development experience across various industries including cellular therapy automation, medical devices and instruments, commercial valving and fluidic systems.
In this article, acoustic cell processing, a unique platform technology that allows for the manipulation of cells with nearly shear-free and low power ultrasonic standing waves, is discussed with its application to cell and gene therapy manufacturing illustrated through case studies.
Latest Advances in Car-T Cell Manufacture & Clinical Developments
ENGLEWOOD CLIFFS, N.J., Jan. 10, 2018 /PRNewswire/ -- Dynamk Capital, a life sciences venture capital fund, today announced an exciting new investment in advancing the commercial production of CAR T and immunotherapies by adding FloDesign Sonics to its growing portfolio. Dynamk's portfolio companies provide technologies and services that enable biopharmaceutical companies around the world to develop therapeutics faster and produce them more economically.
Pall Life Sciences bags BPI 2016 best downstream application award for Cadence Acoustic Separator System
Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, has announced that the Cadence Acoustic Separator has won the BioProcess International (BPI) Award for best downstream processing application. Celebrated bi-annually since 2012, the BPI Awards are hosted during the BioProcess International Conference in Boston, MA.
Pall Purchases Exclusive License to Cutting-Edge Acoustic Wave Separation Technology from FloDesign Sonics for Biopharm Application
Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, announced the signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications. The AWS technology enables very-high-efficiency continuous removal of the cells in a closed system without centrifugation, thereby streamlining a challenging step in the biologics manufacturing process within a small operating footprint. The technology will complement Pall's industry-leading STAXTM depth filtration products to enable continuous clarification of cell culture, enabling integration of the bioreactor with downstream processing.
When oil and gas are extracted from the earth, water also comes to the surface. Known as produced water, it contains naturally occurring hydrocarbons, salt, bacteria, radioactive material and other compounds, as well as any chemical additives used to ease extraction.